Variant report

Variant	esv10835
Chromosome Location	chr10:95605796-95609228
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 51 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:51 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs547893509	chr10:95608207-95608208	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs111856909	chr10:95608219-95608220	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs377641218	chr10:95608230-95608231	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs200400921	chr10:95608232-95608233	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs142332206	chr10:95608233-95608234	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs188285120	chr10:95608267-95608268	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs201739378	chr10:95608292-95608293	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs148183740	chr10:95608293-95608294	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs201609426	chr10:95608294-95608295	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs35716026	chr10:95608297-95608298	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs79763945	chr10:95608304-95608305	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs191346921	chr10:95608312-95608313	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs536570478	chr10:95608324-95608325	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs538413087	chr10:95608332-95608333	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs553173530	chr10:95608372-95608373	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs78928849	chr10:95608373-95608374	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs11187710	chr10:95608398-95608399	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs555047100	chr10:95608456-95608457	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs574882220	chr10:95608487-95608488	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs543790665	chr10:95608510-95608511	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs563566011	chr10:95608514-95608515	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs577098792	chr10:95608531-95608532	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs114565623	chr10:95608556-95608557	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs559481883	chr10:95608557-95608558	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs10430654	chr10:95608575-95608576	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs141673225	chr10:95608594-95608595	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs561816116	chr10:95608602-95608603	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs10430655	chr10:95608662-95608663	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs114417361	chr10:95608663-95608664	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs570376251	chr10:95608664-95608665	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs150125417	chr10:95608719-95608720	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs546923710	chr10:95608837-95608838	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs17109487	chr10:95608869-95608870	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs535639691	chr10:95608870-95608871	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs7092643	chr10:95608895-95608896	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs183883176	chr10:95608957-95608958	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs537176363	chr10:95608961-95608962	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs533147969	chr10:95608962-95608963	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs138271297	chr10:95608979-95608980	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs189857608	chr10:95608980-95608981	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs181503413	chr10:95608989-95608990	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs559617320	chr10:95609027-95609028	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs11187711	chr10:95609036-95609037	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs7076661	chr10:95609050-95609051	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs562175366	chr10:95609055-95609056	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs530602311	chr10:95609132-95609133	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs187147969	chr10:95609156-95609157	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs372524675	chr10:95609157-95609158	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs532958168	chr10:95609161-95609162	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs7092830	chr10:95609183-95609184	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Usher syndrome	20538994	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Paraganglioma	17535989	CNVD
Submicroscopic aberration syndrome	21292638	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Colorectal cancer	18645599	CNVD
Polyposis syndrome	18645599	CNVD
Prostate cancer	17245344	CNVD
Glioblastoma multiforme	17369134	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	22032731	CNVD
Ovarian cancer	20844748	CNVD
Glioblastoma multiforme	17002787	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21364760	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Wilms tumour	21544195	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Urothelial carcinoma	21177765	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cervical cancer	21062161	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	24453001	CNVD
Breast cancer	16608533	CNVD
Sezary syndrome	18413736	CNVD
Intracranial aneurysm	16715129	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:20 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:95608200-95611400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
2	chr10:95608400-95609000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
3	chr10:95608400-95609000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
4	chr10:95608400-95610400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
5	chr10:95608600-95608800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
6	chr10:95608600-95609200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr10:95608600-95609600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
8	chr10:95608600-95610800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
9	chr10:95608600-95611000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
10	chr10:95608800-95609000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
11	chr10:95608800-95609400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
12	chr10:95608800-95609400	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr10:95608800-95610600	Enhancers	Fetal Lung	lung
14	chr10:95609000-95609200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
15	chr10:95609000-95609200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr10:95609000-95609400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
17	chr10:95609000-95609600	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
18	chr10:95609000-95609800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
19	chr10:95609000-95611000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr10:95609200-95610800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links